These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 35005213)
1. Association between myocardial fibrosis, as assessed with cardiac magnetic resonance T1 mapping, and persistent dyspnea after pulmonary embolism. Gleditsch J; Jervan Ø; Tavoly M; Geier O; Holst R; Klok FA; Ghanima W; Hopp E Int J Cardiol Heart Vasc; 2022 Feb; 38():100935. PubMed ID: 35005213 [TBL] [Abstract][Full Text] [Related]
2. Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension. Roller FC; Wiedenroth C; Breithecker A; Liebetrau C; Mayer E; Schneider C; Rolf A; Hamm C; Krombach GA Eur Radiol; 2017 May; 27(5):1980-1991. PubMed ID: 27651142 [TBL] [Abstract][Full Text] [Related]
3. Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI. Ando K; Nagao M; Watanabe E; Sakai A; Suzuki A; Nakao R; Ishizaki U; Sakai S; Hagiwara N Eur Radiol; 2020 Aug; 30(8):4327-4336. PubMed ID: 32211964 [TBL] [Abstract][Full Text] [Related]
5. Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice. Thongsongsang R; Songsangjinda T; Tanapibunpon P; Krittayaphong R BMC Cardiovasc Disord; 2021 Jun; 21(1):270. PubMed ID: 34082703 [TBL] [Abstract][Full Text] [Related]
6. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy. Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging. Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159 [TBL] [Abstract][Full Text] [Related]
8. Myocardial T1-mapping and extracellular volume in pulmonary arterial hypertension: A systematic review and meta-analysis. Alabed S; Saunders L; Garg P; Shahin Y; Alandejani F; Rolf A; Puntmann VO; Nagel E; Wild JM; Kiely DG; Swift AJ Magn Reson Imaging; 2021 Jun; 79():66-75. PubMed ID: 33745961 [TBL] [Abstract][Full Text] [Related]
9. Age and Gender Impact the Measurement of Myocardial Interstitial Fibrosis in a Healthy Adult Chinese Population: A Cardiac Magnetic Resonance Study. Dong Y; Yang D; Han Y; Cheng W; Sun J; Wan K; Liu H; Greiser A; Zhou X; Chen Y Front Physiol; 2018; 9():140. PubMed ID: 29559916 [No Abstract] [Full Text] [Related]
10. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1. Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587 [TBL] [Abstract][Full Text] [Related]
11. Myocardial Native T Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571 [TBL] [Abstract][Full Text] [Related]
12. Native T1 Relaxation Time and Extracellular Volume Fraction as Accurate Markers of Diffuse Myocardial Fibrosis in Heart Valve Disease - Comparison With Targeted Left Ventricular Myocardial Biopsy. Kockova R; Kacer P; Pirk J; Maly J; Sukupova L; Sikula V; Kotrc M; Barciakova L; Honsova E; Maly M; Kautzner J; Sedmera D; Penicka M Circ J; 2016 Apr; 80(5):1202-9. PubMed ID: 26984717 [TBL] [Abstract][Full Text] [Related]
13. Myocardial extracellular volume assessed by cardiovascular magnetic resonance may predict adverse left ventricular remodeling in rheumatic heart disease after valvular surgery. Li S; Wang S; Yu J; Sun J; Cheng W; Liu J; Pu H; Chen Y; Peng L Quant Imaging Med Surg; 2022 Apr; 12(4):2487-2497. PubMed ID: 35371927 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). Liu CY; Liu YC; Wu C; Armstrong A; Volpe GJ; van der Geest RJ; Liu Y; Hundley WG; Gomes AS; Liu S; Nacif M; Bluemke DA; Lima JAC J Am Coll Cardiol; 2013 Oct; 62(14):1280-1287. PubMed ID: 23871886 [TBL] [Abstract][Full Text] [Related]
15. Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference. Foussier C; Barral PA; Jerosh-Herold M; Gariboldi V; Rapacchi S; Gallon A; Bartoli A; Bentatou Z; Guye M; Bernard M; Jacquier A Diagn Interv Imaging; 2021 Mar; 102(3):163-169. PubMed ID: 32830084 [TBL] [Abstract][Full Text] [Related]
16. Associations between Cardiac Magnetic Resonance T1 Mapping Parameters and Ventricular Arrhythmia in Patients with Chagas Disease. Pinheiro MVT; Moll-Bernardes RJ; Camargo GC; Siqueira FP; Azevedo CF; Holanda MT; Mendes FSNS; Sangenis LHC; Mediano MFF; Sousa AS Am J Trop Med Hyg; 2020 Aug; 103(2):745-751. PubMed ID: 32431281 [TBL] [Abstract][Full Text] [Related]
17. Diffuse Myocardial Fibrosis and Diastolic Function in Aortic Stenosis. Lee HJ; Lee H; Kim SM; Park JB; Kim EK; Chang SA; Park E; Kim HK; Lee W; Kim YJ; Lee SC; Park SW; Sohn DW; Oh JK; Park SJ; Lee SP JACC Cardiovasc Imaging; 2020 Dec; 13(12):2561-2572. PubMed ID: 32828787 [TBL] [Abstract][Full Text] [Related]
18. Myocardial Extracellular Volume Fraction and T1 Mapping by Cardiac Magnetic Resonance Compared Between Patients With and Without Type 2 Diabetes, and the Effect of ECV and T2D on Cardiovascular Outcomes. Laohabut I; Songsangjinda T; Kaolawanich Y; Yindeengam A; Krittayaphong R Front Cardiovasc Med; 2021; 8():771363. PubMed ID: 34950715 [No Abstract] [Full Text] [Related]
19. Effects of pulmonary rehabilitation on cardiac magnetic resonance parameters in patients with persistent dyspnea following pulmonary embolism. Gleditsch J; Jervan Ø; Haukeland-Parker S; Tavoly M; Geier O; Holst R; Klok FA; Johannessen HH; Ghanima W; Hopp E Int J Cardiol Heart Vasc; 2022 Jun; 40():100995. PubMed ID: 35345773 [TBL] [Abstract][Full Text] [Related]